Jasper Therapeutics’ stock jumps by 467% after positive drug trial


Jasper Therapeutics' stock rose as high as $3.80 a piece before closing at $2.74, the first time it has traded above $1 since late in September.

Previous In a reversal, Centene wins back two lucrative Medicaid contracts
Next Pizza Factory franchise planned for former Joe Caribe restaurant space in Auburn